Safety Shot Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Safety Shot (Nasdaq: SHOT) has received a 180-day extension from Nasdaq until December 29, 2025, to regain compliance with the minimum bid price requirement. The extension was granted based on the company meeting all other Nasdaq Capital Market listing requirements except the bid price requirement.
The company's stock will continue trading on Nasdaq under "SHOT" while it works to meet the minimum $1.00 bid price requirement for at least 10 consecutive business days. CEO Jarrett Boon noted that the Board has approved several strategic options to address this requirement while focusing on business strategy and Yerbaé integration.
Positive
- Board has proactively approved strategic options to address compliance
- Company meets all other Nasdaq listing requirements
- Additional 180 days provided to regain compliance
- Opportunity to appeal if compliance not met by deadline
Negative
- Risk of delisting if $1.00 minimum bid price not maintained for 10 consecutive days by December 29, 2025
- Current stock price remains below Nasdaq minimum requirement
- Potential need for strategic actions that could impact shareholders
Insights
Safety Shot received crucial 180-day Nasdaq extension to meet $1 minimum share price requirement, avoiding immediate delisting risk.
Safety Shot has been granted a significant 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement, extending their deadline to December 29, 2025. This extension indicates that while the company's stock price has been trading below the required $1.00 minimum threshold, they've met all other Nasdaq Capital Market listing requirements, including adequate market value of publicly held shares.
This development has no immediate impact on Safety Shot's listing status, as their shares will continue trading under the "SHOT" symbol. However, the extension represents a critical regulatory reprieve that buys management valuable time to implement remedial measures. To satisfy the requirement, Safety Shot needs to maintain a closing bid price of at least $1.00 for a minimum of 10 consecutive business days during this extension period.
The CEO's statement that the board has "proactively approved several strategic options" likely indicates they're considering potential remedies such as a reverse stock split, which would artificially increase the share price by reducing the number of outstanding shares. The company's reference to the "exciting integration of Yerbaé" suggests they're also banking on business developments to potentially drive organic share price appreciation.
If Safety Shot fails to regain compliance by the December deadline, they face potential delisting, though they would still have appeal rights before a Nasdaq Hearings Panel. This extension essentially represents a yellow warning flag rather than an immediate red flag for investors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SCOTTSDALE, AZ, July 16, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) today announced it has received a notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") granting the Company an additional 180-calendar day compliance period, until December 29, 2025, to regain compliance with the minimum bid price requirement.
Nasdaq's determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period.
This notification has no immediate effect on the listing of the Company’s common stock, which will continue to trade on The Nasdaq Capital Market under the ticker symbol “SHOT”.
“We are pleased to have received this extension from Nasdaq, which provides us with additional time to regain compliance,” said Jarrett Boon, CEO of Safety Shot. “Our Board of Directors has already proactively approved several strategic options to satisfy the bid price requirement. We will continue to monitor our stock price and are confident in our ability to resolve this matter within the extended compliance period, ensuring our focus remains on executing our business strategy and completing the exciting integration of Yerbaé.”
To regain compliance, the closing bid price of the Company’s common stock must be at least
About Safety Shot, Inc. Safety Shot, Inc., a wellness and dietary supplement company, has developed Sure Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon.
Investor Relations: Phone: 561-244-7100 Email: investors@drinksafetyshot.com
Forward-Looking Statements: This press release contains forward-looking statements, including statements about the Company’s ability to regain compliance with the Nasdaq minimum bid price requirement. These forward-looking statements are based on the current expectations of the management of Safety Shot and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Safety Shot, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.